1.8M
XNAS Volume
High volume today
XNAS 21 Mar, 2025 5:30 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Thomas W. Beetham | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 225,814 | 225,814 | - | - | Stock Option (Right to Buy) | |
| Thomas W. Beetham | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 37,636 | 37,636 | - | - | Restricted Stock Units | |
| Stephen Mahoney | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 440,565 | 440,565 | - | - | Stock Option (Right to Buy) | |
| Stephen Mahoney | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 73,428 | 73,428 | - | - | Restricted Stock Units | |
| Seth Harmon | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 25,068 | 25,068 | - | - | Restricted Stock Units | |
| Seth Harmon | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 150,407 | 150,407 | - | - | Stock Option (Right to Buy) | |
| Jennifer Tousignant | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 124,072 | 124,072 | - | - | Stock Option (Right to Buy) | |
| Jennifer Tousignant | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 20,679 | 20,679 | - | - | Restricted Stock Units | |
| Thomas W. Beetham | Chief Operating Officer | Purchase of securities on an exchange or from another person at price $ 23.41 per share. | 27 Sep 2024 | 5,000 | 6,000 (0%) | 0% | 23.4 | 117,050 | Common Stock |
| Stephen Mahoney | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 23.33 per share. | 27 Sep 2024 | 21,400 | 21,400 (0%) | 0% | 23.3 | 499,262 | Common Stock |
| Arlene M. Morris | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2024 | 21,000 | 21,000 | - | - | Stock Option (Right to Buy) | |
| Jennifer K. Moses | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2024 | 21,000 | 21,000 | - | - | Stock Option (Right to Buy) | |
| Peter Harwin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2024 | 21,000 | 21,000 | - | - | Stock Option (Right to Buy) | |
| Tomas Kiselak | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2024 | 21,000 | 21,000 | - | - | Stock Option (Right to Buy) | |
| Sarah Gheuens | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2024 | 21,000 | 21,000 | - | - | Stock Option (Right to Buy) | |
| Jennifer Tousignant | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2024 | 290,000 | 290,000 | - | - | Stock Option (Right to Buy) | |
| Ciulla Thomas | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2024 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Lara Meisner | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.03 per share. | 15 Jun 2023 | 2,269 | 32,240 (0%) | 0% | 23.0 | 52,255 | Common Stock |
| Lara Meisner | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2023 | 28 | 37,453 | - | - | Stock Option (Right to Buy) | |
| Lara Meisner | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2023 | 2,269 | 37,481 | - | - | Stock Option (Right to Buy) | |
| Lara Meisner | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 28.33 per share. | 15 Jun 2023 | 27 | 29,971 (0%) | 0% | 28.3 | 765 | Common Stock |
| Lara Meisner | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.04 per share. | 15 Jun 2023 | 27 | 29,998 (0%) | 0% | 23.0 | 622 | Common Stock |
| Lara Meisner | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 28.02 per share. | 15 Jun 2023 | 2,269 | 29,971 (0%) | 0% | 28.0 | 63,577 | Common Stock |
| Lara Meisner | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.51 per share. | 02 Jun 2023 | 5,126 | 35,097 (0%) | 0% | 18.5 | 94,882 | Common Stock |
| Lara Meisner | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jun 2023 | 5,126 | 84,375 | - | - | Stock Option (Right to Buy) | |
| Lara Meisner | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jun 2023 | 499 | 89,501 | - | - | Stock Option (Right to Buy) | |
| Lara Meisner | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jun 2023 | 1,875 | 18,128 | - | - | Stock Option (Right to Buy) | |
| Lara Meisner | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 25.02 per share. | 02 Jun 2023 | 5,126 | 29,971 (0%) | 0% | 25.0 | 128,253 | Common Stock |
| Lara Meisner | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 25.03 per share. | 02 Jun 2023 | 499 | 29,971 (0%) | 0% | 25.0 | 12,490 | Common Stock |
| Lara Meisner | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.51 per share. | 02 Jun 2023 | 499 | 30,470 (0%) | 0% | 18.5 | 9,236 | Common Stock |
| Lara Meisner | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 24.21 per share. | 02 Jun 2023 | 1,875 | 29,971 (0%) | 0% | 24.2 | 45,394 | Common Stock |
| Lara Meisner | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.00 per share. | 02 Jun 2023 | 1,875 | 31,846 (0%) | 0% | 14 | 26,250 | Common Stock |
| Scott D. Myers | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 25.37 per share. | 12 Apr 2023 | 4,000 | 259,500 (0%) | 0% | 25.4 | 101,479 | Common Stock |
| Scott D. Myers | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 29.15 per share. | 13 Mar 2023 | 5,500 | 255,500 (0%) | 0% | 29.1 | 160,324 | Common Stock |
| Lara Meisner | General Counsel and Secretary | Sale of securities on an exchange or to another person at price $ 29.07 per share. | 09 Mar 2023 | 29,971 | 0 (0%) | 0% | 29.1 | 871,257 | Common Stock |
| Barrett Katz | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2023 | 108,000 | 108,000 | - | - | Stock Option (Right to Buy) | |
| Kristian Humer | CFO and CBO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2023 | 108,000 | 108,000 | - | - | Stock Option (Right to Buy) | |
| Lara Meisner | General Counsel and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2023 | 108,000 | 108,000 | - | - | Stock Option (Right to Buy) | |
| Carrie Melvin | COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2023 | 54,000 | 54,000 | - | - | Stock Option (Right to Buy) | |
| Scott D. Myers | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2023 | 1,000,000 | 1,000,000 | - | - | Stock Option (Right to Buy) | |
| Scott D. Myers | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2023 | 250,000 | 250,000 (0%) | 0% | 0 | Common Stock | |
| Jonathan Violin | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2023 | 50,000 | 239,205 | - | - | Stock Option (Right to Buy) | |
| Jonathan Violin | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 36.80 per share. | 02 Feb 2023 | 50,000 | 480,905 (1%) | 0% | 36.8 | 1,840,000 | Common Stock |
| Jonathan Violin | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.15 per share. | 02 Feb 2023 | 50,000 | 530,905 (1%) | 0% | 0.2 | 7,500 | Common Stock |
| Jonathan Violin | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 36.80 per share. | 02 Feb 2023 | 50,000 | 430,905 (1%) | 0% | 36.8 | 1,840,000 | Common Stock |
| Lara Meisner | General Counsel and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.03 per share. | 23 Jan 2023 | 4,971 | 4,971 (0%) | 0% | 23.0 | 114,482 | Common Stock |
| Lara Meisner | General Counsel and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.00 per share. | 23 Jan 2023 | 1,872 | 6,843 (0%) | 0% | 14 | 26,208 | Common Stock |
| Lara Meisner | General Counsel and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jan 2023 | 1,872 | 20,003 | - | - | Stock Option (Right to Buy) | |
| Lara Meisner | General Counsel and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jan 2023 | 4,971 | 39,750 | - | - | Stock Option (Right to Buy) | |
| Lara Meisner | General Counsel and Secretary | Sale of securities on an exchange or to another person at price $ 35.66 per share. | 23 Jan 2023 | 6,843 | 0 (0%) | 0% | 35.7 | 244,021 | Common Stock |
| Barrett Katz | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 37.01 per share. | 13 Jan 2023 | 4,147 | 0 (0%) | 0% | 37.0 | 153,480 | Common Stock |
| Barrett Katz | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2023 | 24,853 | 267,000 | - | - | Stock Option (Right to Buy) | |
| Barrett Katz | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2023 | 4,147 | 291,853 | - | - | Stock Option (Right to Buy) | |
| Barrett Katz | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 37.21 per share. | 13 Jan 2023 | 24,853 | 0 (0%) | 0% | 37.2 | 924,780 | Common Stock |
| Barrett Katz | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.03 per share. | 13 Jan 2023 | 24,853 | 24,853 (0%) | 0% | 23.0 | 572,365 | Common Stock |
| Barrett Katz | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.03 per share. | 13 Jan 2023 | 4,147 | 4,147 (0%) | 0% | 23.0 | 95,505 | Common Stock |
| Barrett Katz | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 33.04 per share. | 09 Jan 2023 | 12,623 | 0 (0%) | 0% | 33.0 | 417,064 | Common Stock |
| Barrett Katz | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jan 2023 | 47,377 | 296,000 | - | - | Stock Option (Right to Buy) | |
| Barrett Katz | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jan 2023 | 12,623 | 343,377 | - | - | Stock Option (Right to Buy) | |
| Barrett Katz | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 35.30 per share. | 09 Jan 2023 | 47,377 | 0 (0%) | 0% | 35.3 | 1,672,408 | Common Stock |
| Barrett Katz | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.03 per share. | 09 Jan 2023 | 47,377 | 47,377 (0%) | 0% | 23.0 | 1,091,092 | Common Stock |
| Barrett Katz | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.03 per share. | 09 Jan 2023 | 12,623 | 12,623 (0%) | 0% | 23.0 | 290,708 | Common Stock |
| Lara Meisner | General Counsel and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.03 per share. | 20 Dec 2022 | 600 | 600 (0%) | 0% | 23.0 | 13,818 | Common Stock |
| Lara Meisner | General Counsel and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Dec 2022 | 16,326 | 44,721 | - | - | Stock Option (Right to Buy) | |
| Lara Meisner | General Counsel and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Dec 2022 | 600 | 61,047 | - | - | Stock Option (Right to Buy) | |
| Lara Meisner | General Counsel and Secretary | Sale of securities on an exchange or to another person at price $ 29.19 per share. | 20 Dec 2022 | 16,326 | 0 (0%) | 0% | 29.2 | 476,556 | Common Stock |
| Lara Meisner | General Counsel and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.03 per share. | 20 Dec 2022 | 16,326 | 16,326 (0%) | 0% | 23.0 | 375,988 | Common Stock |
| Lara Meisner | General Counsel and Secretary | Sale of securities on an exchange or to another person at price $ 28.07 per share. | 20 Dec 2022 | 600 | 0 (0%) | 0% | 28.1 | 16,842 | Common Stock |
| Lara Meisner | General Counsel and Secretary | Sale of securities on an exchange or to another person at price $ 28.44 per share. | 15 Dec 2022 | 1,297 | 0 (0%) | 0% | 28.4 | 36,887 | Common Stock |
| Lara Meisner | General Counsel and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2022 | 1,297 | 61,647 | - | - | Stock Option (Right to Buy) | |
| Lara Meisner | General Counsel and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2022 | 300 | 62,944 | - | - | Stock Option (Right to Buy) | |
| Lara Meisner | General Counsel and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.03 per share. | 15 Dec 2022 | 1,297 | 1,297 (0%) | 0% | 23.0 | 29,870 | Common Stock |
| Lara Meisner | General Counsel and Secretary | Sale of securities on an exchange or to another person at price $ 28.08 per share. | 15 Dec 2022 | 300 | 0 (0%) | 0% | 28.1 | 8,424 | Common Stock |
| Lara Meisner | General Counsel and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.03 per share. | 15 Dec 2022 | 300 | 300 (0%) | 0% | 23.0 | 6,909 | Common Stock |
| Lara Meisner | General Counsel and Secretary | Sale of securities on an exchange or to another person at price $ 28.05 per share. | 12 Dec 2022 | 600 | 0 (0%) | 0% | 28.1 | 16,830 | Common Stock |
| Lara Meisner | General Counsel and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Dec 2022 | 15,656 | 63,244 | - | - | Stock Option (Right to Buy) | |
| Lara Meisner | General Counsel and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Dec 2022 | 600 | 78,900 | - | - | Stock Option (Right to Buy) | |
| Lara Meisner | General Counsel and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.03 per share. | 12 Dec 2022 | 600 | 600 (0%) | 0% | 23.0 | 13,818 | Common Stock |
| Lara Meisner | General Counsel and Secretary | Sale of securities on an exchange or to another person at price $ 28.12 per share. | 12 Dec 2022 | 15,656 | 0 (0%) | 0% | 28.1 | 440,247 | Common Stock |
| Lara Meisner | General Counsel and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.03 per share. | 12 Dec 2022 | 15,656 | 15,656 (0%) | 0% | 23.0 | 360,558 | Common Stock |
| Lara Meisner | General Counsel and Secretary | Sale of securities on an exchange or to another person at price $ 22.05 per share. | 15 Nov 2022 | 8,125 | 0 (0%) | 0% | 22.0 | 179,156 | Common Stock |
| Lara Meisner | General Counsel and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.00 per share. | 15 Nov 2022 | 8,125 | 8,125 (0%) | 0% | 14 | 113,750 | Common Stock |
| Lara Meisner | General Counsel and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2022 | 8,125 | 21,875 | - | - | Stock Option (Right to Buy) | |
| Arlene M. Morris | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 12,500 | 12,500 | - | - | Stock Option (Right to Buy) | |
| Jennifer K. Moses | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 12,500 | 12,500 | - | - | Stock Option (Right to Buy) | |
| Peter Harwin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 12,500 | 12,500 | - | - | Stock Option (Right to Buy) | |
| Tomas Kiselak | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 12,500 | 12,500 | - | - | Stock Option (Right to Buy) | |
| Jonathan Violin | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 12.20 per share. | 01 Jun 2022 | 30,000 | 480,905 (1%) | 0% | 12.2 | 366,000 | Common Stock |
| Jonathan Violin | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 13.04 per share. | 02 May 2022 | 30,000 | 510,905 (1%) | 0% | 13.0 | 391,200 | Common Stock |
| Jonathan Violin | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 18.93 per share. | 01 Apr 2022 | 3,600 | 540,905 (1%) | 0% | 18.9 | 68,148 | Common Stock |
| Jonathan Violin | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 18.92 per share. | 01 Apr 2022 | 26,400 | 544,505 (1%) | 0% | 18.9 | 499,488 | Common Stock |
| Jonathan Violin | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 17.36 per share. | 01 Mar 2022 | 11,106 | 570,905 (1%) | 0% | 17.4 | 192,800 | Common Stock |
| Jonathan Violin | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 17.82 per share. | 01 Mar 2022 | 18,894 | 582,011 (1%) | 0% | 17.8 | 336,691 | Common Stock |
| Barrett Katz | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2022 | 110,000 | 110,000 | - | - | Stock Option (Right to Buy) | |
| Kristian Humer | CFO and CBO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2022 | 90,000 | 90,000 | - | - | Stock Option (Right to Buy) | |
| Lara Meisner | General Counsel and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2022 | 90,000 | 90,000 | - | - | Stock Option (Right to Buy) | |
| Jonathan Violin | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 280,000 | 280,000 | - | - | Stock Option (Right to Buy) | |
| Jonathan Violin | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 19.16 per share. | 01 Feb 2022 | 909 | 600,905 (1%) | 0% | 19.2 | 17,416 | Common Stock |
| Jonathan Violin | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 18.47 per share. | 01 Feb 2022 | 12,340 | 601,814 (1%) | 0% | 18.5 | 227,920 | Common Stock |
| Jonathan Violin | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 19.55 per share. | 01 Feb 2022 | 16,751 | 614,154 (1%) | 0% | 19.5 | 327,482 | Common Stock |
| Kristian Humer | CFO and CBO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jul 2021 | 360,000 | 360,000 | - | - | Stock Option (Right to Buy) | |
| Jennifer K. Moses | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2021 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Arlene M. Morris | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2021 | 12,500 | 12,500 | - | - | Stock Option (Right to Buy) | |
| Peter Harwin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2021 | 12,500 | 12,500 | - | - | Stock Option (Right to Buy) | |
| Tomas Kiselak | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2021 | 12,500 | 12,500 | - | - | Stock Option (Right to Buy) | |
| Arlene M. Morris | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2021 | 25,000 | 25,000 | - | - | Director Stock Option (Right to Buy) | |
| Joseph L. Turner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2021 | 25,000 | 25,000 | - | - | Director Stock Option (Right to Buy) | |
| Jeffrey S. Hatfield | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2021 | 25,000 | 25,000 | - | - | Director Stock Option (Right to Buy) | |
| Peter Harwin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2021 | 25,000 | 25,000 | - | - | Director Stock Option (Right to Buy) | |
| Tomas Kiselak | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2021 | 25,000 | 25,000 | - | - | Director Stock Option (Right to Buy) | |
| Jonathan Violin | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2021 | 800,075 | 800,075 | - | - | Employee Stock Option (right to buy) | |
| Jason A. Leverone | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2021 | 311,785 | 311,785 | - | - | Employee Stock Option (right to buy) | |
| Barrett Katz | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2021 | 356,000 | 356,000 | - | - | Employee Stock Option (right to buy) | |
| Lee Rauch | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2021 | 15,000 | 15,000 | - | - | Employee Stock Option (right to buy) | |
| Jonathan Violin | President and COO | Other type of transaction at price $ 0.00 per share. | 27 Oct 2020 | 50,124 | 50,124 (0%) | 0% | - | Common Stock | |
| Jonathan Violin | President and COO | Other type of transaction at price $ 0.00 per share. | 27 Oct 2020 | 9,413 | 9,413 | - | - | Series A Non-Voting Convertible Preferred Stock | |
| Jonathan Violin | President and COO | Other type of transaction at price $ 0.00 per share. | 27 Oct 2020 | 4,338,079 | 4,338,079 | - | - | Employee Stock Option (Right to Buy) | |
| Peter Harwin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Oct 2020 | 24,000 | 24,000 | - | - | Director Stock Option (Right to Buy) | |
| Tomas Kiselak | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Oct 2020 | 24,000 | 24,000 | - | - | Director Stock Option (Right to Buy) | |
| Lee Rauch | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Sep 2020 | 900,000 | 900,000 | - | - | Stock Option (right to buy) | |
| Arlene M. Morris | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2020 | 24,000 | 24,000 | - | - | Stock Option (right to buy) | |
| Kevin Koch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2020 | 24,000 | 24,000 | - | - | Stock Option (right to buy) | |
| Joseph L. Turner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2020 | 24,000 | 24,000 | - | - | Stock Option (right to buy) | |
| Christopher Bowden | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2020 | 24,000 | 24,000 | - | - | Stock Option (right to buy) | |
| Jeffrey S. Hatfield | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2020 | 24,000 | 24,000 | - | - | Stock Option (right to buy) | |
| Thomas E. Hughes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2020 | 24,000 | 24,000 | - | - | Stock Option (right to buy) | |
| Jason A. Leverone | CFO, Treasurer & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Mar 2020 | 11,249 | 0 | - | - | Stock Option (right to buy) | |
| Jason A. Leverone | CFO, Treasurer & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.57 per share. | 13 Mar 2020 | 11,249 | 48,829 (0%) | 0% | 0.6 | 6,412 | Common Stock |
| William S. Marshall | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2020 | 464,000 | 464,000 | - | - | Stock Option (right to buy) | |
| Jason A. Leverone | CFO, Treasurer & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2020 | 185,000 | 185,000 | - | - | Stock Option (right to buy) | |
| Diana Escolar | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2020 | 270,000 | 270,000 | - | - | Stock Option (right to buy) | |
| William S. Marshall | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 1.14 per share. | 31 Dec 2019 | 1,250 | 270,646 (0%) | 0% | 1.1 | 1,424 | Common Stock |
| William S. Marshall | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 2.46 per share. | 31 Dec 2019 | 1,250 | 269,396 (0%) | 0% | 2.5 | 3,071 | Common Stock |
| Jason A. Leverone | CFO, Treasurer & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.57 per share. | 23 Aug 2019 | 3,093 | 36,330 (0%) | 0% | 0.6 | 1,763 | Common Stock |
| Jason A. Leverone | CFO, Treasurer & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Aug 2019 | 3,093 | 0 | - | - | Stock Option (right to buy) | |
| Arlene M. Morris | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jun 2019 | 12,000 | 12,000 | - | - | Stock Option (right to buy) | |
| Kevin Koch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jun 2019 | 12,000 | 12,000 | - | - | Stock Option (right to buy) | |
| Joseph L. Turner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jun 2019 | 12,000 | 12,000 | - | - | Stock Option (right to buy) | |
| Christopher Bowden | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jun 2019 | 12,000 | 12,000 | - | - | Stock Option (right to buy) | |
| Jeffrey S. Hatfield | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jun 2019 | 12,000 | 12,000 | - | - | Stock Option (right to buy) | |
| Thomas E. Hughes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jun 2019 | 12,000 | 12,000 | - | - | Stock Option (right to buy) | |
| Thomas E. Hughes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2019 | 10,106 | 10,106 | - | - | Stock Option (right to buy) | |
| Paul D. Rubin | EVP, Research & Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2019 | 87,000 | 87,000 | - | - | Stock Option (right to buy) | |
| William S. Marshall | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2019 | 232,000 | 232,000 | - | - | Stock Option (right to buy) | |
| Jason A. Leverone | CFO, Treasurer & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2019 | 75,000 | 75,000 | - | - | Stock Option (right to buy) | |
| Adam S. Levy | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2019 | 74,000 | 74,000 | - | - | Stock Option (right to buy) | |
| Thomas E. Hughes | None | Purchase of securities on an exchange or from another person at price $ 4.77 per share. | 11 Oct 2018 | 10,000 | 12,827 (0%) | 0% | 4.8 | 47,697 | Common Stock |
| Jason A. Leverone | CFO, Treasurer & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Aug 2018 | 29,530 | 0 | - | - | Stock Option (right to buy) | |
| Jason A. Leverone | CFO, Treasurer & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.57 per share. | 07 Aug 2018 | 29,530 | 30,737 (0%) | 0% | 0.6 | 16,832 | Common Stock |
| Arlene M. Morris | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2018 | 12,000 | 12,000 | - | - | Stock Option (right to buy) | |
| Kevin Koch | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2018 | 12,000 | 12,000 | - | - | Stock Option (right to buy) | |
| Joseph L. Turner | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2018 | 12,000 | 12,000 | - | - | Stock Option (right to buy) | |
| Christopher Bowden | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2018 | 12,000 | 12,000 | - | - | Stock Option (right to buy) | |
| Jeffrey S. Hatfield | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2018 | 12,000 | 12,000 | - | - | Stock Option (right to buy) | |
| Thomas E. Hughes | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2018 | 12,000 | 12,000 | - | - | Stock Option (right to buy) | |
| Bruce Booth | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2018 | 12,000 | 12,000 | - | - | Stock Option (right to buy) | |
| Bruce Booth | None | Purchase of securities on an exchange or from another person at price $ 5.50 per share. | 13 Feb 2018 | 545,454 | 1,351,090 (4%) | 1% | 5.5 | 2,999,997 | Common Stock |
| William S. Marshall | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2018 | 115,818 | 0 | - | - | Stock Option (right to buy) | |
| William S. Marshall | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.57 per share. | 13 Feb 2018 | 115,818 | 265,646 (0%) | 0% | 0.6 | 66,016 | Common Stock |
| Adam S. Levy | Chief Business Officer | Purchase of securities on an exchange or from another person at price $ 5.50 per share. | 13 Feb 2018 | 9,090 | 10,540 (0%) | 0% | 5.5 | 49,995 | Common Stock |
| Paul D. Rubin | EVP, Research & Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2018 | 85,000 | 85,000 | - | - | Stock Option (right to buy) | |
| William S. Marshall | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2018 | 245,000 | 245,000 | - | - | Stock Option (right to buy) | |
| Jason A. Leverone | CFO, Treasurer & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2018 | 75,000 | 75,000 | - | - | Stock Option (right to buy) | |
| Adam S. Levy | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2018 | 80,000 | 80,000 | - | - | Stock Option (right to buy) | |
| Thomas E. Hughes | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2018 | 3,426 | 3,426 | - | - | Stock Option (right to buy) | |
| Bruce Booth | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2018 | 10,191 | 10,191 | - | - | Stock Option (right to buy) | |
| Thomas E. Hughes | None | Sale of securities on an exchange or to another person at price $ 8.00 per share. | 20 Dec 2017 | 12,000 | 2,827 (0%) | 0% | 8 | 96,000 | Common Stock |
| Kevin Koch | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2017 | 12,000 | 12,000 | - | - | Stock Option (right to buy) | |
| Joseph L. Turner | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2017 | 12,000 | 12,000 | - | - | Stock Option (right to buy) | |
| Kyle A. Lefkoff | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2017 | 12,000 | 12,000 | - | - | Stock Option (right to buy) | |
| Thomas E. Hughes | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2017 | 12,000 | 12,000 | - | - | Stock Option (right to buy) | |
| Bruce Booth | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2017 | 12,000 | 12,000 | - | - | Stock Option (right to buy) | |
| John Creecy | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2017 | 12,000 | 12,000 | - | - | Stock Option (right to buy) | |
| Adam S. Levy | Chief Business Officer | Purchase of securities on an exchange or from another person at price $ 7.55 per share. | 22 Jun 2017 | 200 | 200 (0%) | 0% | 7.6 | 1,510 | Common Stock |
| Thomas E. Hughes | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Mar 2017 | 1,191 | 1,191 | - | - | Stock Option (right to buy) | |
| Thomas E. Hughes | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Mar 2017 | 778 | 14,840 (0%) | 0% | 0 | Common Stock | |
| Bruce Booth | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Mar 2017 | 6,844 | 6,844 | - | - | Stock Option (right to buy) | |
| Kyle A. Lefkoff | None | Sale of securities on an exchange or to another person at price $ 14.38 per share. | 09 Mar 2017 | 2,500 | 466,773 (2%) | 0% | 14.4 | 35,962 | Common Stock |
| Kyle A. Lefkoff | None | Sale of securities on an exchange or to another person at price $ 14.31 per share. | 09 Mar 2017 | 3,300 | 463,473 (2%) | 0% | 14.3 | 47,229 | Common Stock |
| Kyle A. Lefkoff | None | Sale of securities on an exchange or to another person at price $ 16.24 per share. | 06 Mar 2017 | 608 | 474,273 (2%) | 0% | 16.2 | 9,874 | Common Stock |
| Kyle A. Lefkoff | None | Sale of securities on an exchange or to another person at price $ 14.70 per share. | 06 Mar 2017 | 5,000 | 469,273 (2%) | 0% | 14.7 | 73,514 | Common Stock |
| Kyle A. Lefkoff | None | Sale of securities on an exchange or to another person at price $ 15.71 per share. | 06 Mar 2017 | 9,392 | 474,881 (2%) | 0% | 15.7 | 147,590 | Common Stock |
| Kyle A. Lefkoff | None | Sale of securities on an exchange or to another person at price $ 13.79 per share. | 24 Feb 2017 | 1,500 | 486,531 (2%) | 0% | 13.8 | 20,687 | Common Stock |
| Kyle A. Lefkoff | None | Sale of securities on an exchange or to another person at price $ 13.54 per share. | 24 Feb 2017 | 2,258 | 484,273 (2%) | 0% | 13.5 | 30,580 | Common Stock |
| Kyle A. Lefkoff | None | Sale of securities on an exchange or to another person at price $ 14.04 per share. | 24 Feb 2017 | 6,500 | 488,031 (2%) | 0% | 14.0 | 91,252 | Common Stock |
| Kyle A. Lefkoff | None | Sale of securities on an exchange or to another person at price $ 13.65 per share. | 22 Feb 2017 | 1,800 | 494,531 (2%) | 0% | 13.6 | 24,566 | Common Stock |
| Kyle A. Lefkoff | None | Sale of securities on an exchange or to another person at price $ 14.36 per share. | 22 Feb 2017 | 4,102 | 496,331 (2%) | 0% | 14.4 | 58,886 | Common Stock |
| Paul D. Rubin | EVP, Research & Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2017 | 87,500 | 87,500 | - | - | Stock Option (right to buy) | |
| William S. Marshall | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2017 | 200,000 | 200,000 | - | - | Stock Option (right to buy) | |
| Jason A. Leverone | CFO, Treasurer & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2017 | 77,500 | 77,500 | - | - | Stock Option (right to buy) | |
| Adam S. Levy | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2017 | 87,500 | 87,500 | - | - | Stock Option (right to buy) | |
| Bennett S. Lebow | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.39 per share. | 13 Feb 2017 | 279,067 | 280,600 (1%) | 1% | 5.4 | 1,504,171 | Common Stock |
| David A. Gonyer | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2017 | 1,200 | 0 | - | - | Stock Option (Right to Buy) | |
| David A. Gonyer | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.65 per share. | 08 Feb 2017 | 1,200 | 1,899 (0%) | 0% | 7.7 | 9,180 | Common Stock |
| Robin L. Smith | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.65 per share. | 03 Feb 2017 | 1,200 | 1,900 (0%) | 0% | 7.7 | 9,180 | Common Stock |
| Robin L. Smith | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2017 | 1,200 | 0 | - | - | Stock Option (Right to Buy) | |
| Bennett S. Lebow | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2017 | 1,200 | 0 | - | - | Stock Option (Right to Buy) | |
| Bennett S. Lebow | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.65 per share. | 03 Feb 2017 | 1,200 | 1,533 (0%) | 0% | 7.7 | 9,180 | Common Stock |
| Tamara A. Seymour | CFO, Secretary, Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Oct 2016 | 46,000 | 72,994 | - | - | Common Stock | |
| Tamara A. Seymour | CFO, Secretary, Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Oct 2016 | 100,000 | 0 | - | - | Restricted Stock Units | |
| Tamara A. Seymour | CFO, Secretary, Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 31 Oct 2016 | 45,580 | 106,447 | - | - | Common Stock | |
| Tamara A. Seymour | CFO, Secretary, Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 31 Oct 2016 | 20,967 | 52,027 | - | - | Common Stock | |
| Tamara A. Seymour | CFO, Secretary, Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Oct 2016 | 46,000 | 0 | - | - | Restricted Stock Units | |
| Tamara A. Seymour | CFO, Secretary, Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Oct 2016 | 100,000 | 152,027 | - | - | Common Stock | |
| Samuel D. Riccitelli | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 31 Oct 2016 | 103,160 | 571,370 | - | - | Common Stock | |
| Samuel D. Riccitelli | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Oct 2016 | 200,000 | 674,530 | - | - | Common Stock | |
| Samuel D. Riccitelli | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Oct 2016 | 200,000 | 0 | - | - | Restricted Stock Units | |
| Tamara A. Seymour | CFO, Secretary, Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Aug 2016 | 23,000 | 37,478 | - | - | Common Stock | |
| Tamara A. Seymour | CFO, Secretary, Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Aug 2016 | 23,000 | 46,000 | - | - | Restricted Stock Units | |
| Tamara A. Seymour | CFO, Secretary, Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 08 Aug 2016 | 10,484 | 26,994 | - | - | Common Stock | |
| Samuel D. Riccitelli | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Jun 2016 | 124,251 | 0 | - | - | Restricted Stock Units | |
| Samuel D. Riccitelli | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Jun 2016 | 124,251 | 539,365 | - | - | Common Stock | |
| Samuel D. Riccitelli | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 28 Jun 2016 | 64,835 | 474,530 | - | - | Common Stock | |
| Bennett S. Lebow | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2016 | 18,000 | 18,000 | - | - | Stock Option (Right to Buy) | |
| Robin L. Smith | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2016 | 18,000 | 18,000 | - | - | Stock Option (Right to Buy) | |
| Douglas A. Schuling | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2016 | 18,000 | 18,000 | - | - | Stock Option (Right to Buy) | |
| David A. Gonyer | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2016 | 18,000 | 18,000 | - | - | Stock Option (Right to Buy) | |
| Tamara A. Seymour | CFO, Secretary, Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2016 | 100,000 | 100,000 | - | - | Restricted Stock Units | |
| Samuel D. Riccitelli | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2016 | 200,000 | 200,000 | - | - | Restricted Stock Units | |
| Samuel D. Riccitelli | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 11 Feb 2016 | 54,268 | 415,114 | - | - | Common Stock | |
| Samuel D. Riccitelli | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2016 | 124,252 | 469,382 | - | - | Common Stock | |
| Samuel D. Riccitelli | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2016 | 124,252 | 124,251 | - | - | Restricted Stock Units | |
| Samuel D. Riccitelli | Director, President & CEO | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 19 Nov 2015 | 7,000 | 345,130 | - | - | Common Stock | |
| Samuel D. Riccitelli | Director, President & CEO | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 19 Nov 2015 | 7,000 | 338,130 | - | - | Common Stock | |
| Tamara A. Seymour | CFO, Secretary, Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Aug 2015 | 60,000 | 60,000 | - | - | Employee Stock Option (Right to Buy) | |
| Bennett S. Lebow | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Aug 2015 | 5,000 | 5,000 | - | - | Common Stock | |
| Bennett S. Lebow | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Aug 2015 | 18,000 | 18,000 | - | - | Stock Option (Right to Buy) | |
| Robin L. Smith | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Aug 2015 | 18,000 | 18,000 | - | - | Stock Option (Right to Buy) | |
| Robin L. Smith | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Aug 2015 | 4,125 | 5,500 | - | - | Common Stock | |
| Robin L. Smith | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Aug 2015 | 5,000 | 10,500 | - | - | Common Stock | |
| Robin L. Smith | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Aug 2015 | 4,125 | 0 | - | - | Restricted Stock Units | |
| Douglas A. Schuling | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Aug 2015 | 4,125 | 0 | - | - | Restricted Stock Units | |
| Douglas A. Schuling | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Aug 2015 | 5,000 | 10,500 | - | - | Common Stock | |
| Douglas A. Schuling | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Aug 2015 | 4,125 | 5,500 | - | - | Common Stock | |
| Douglas A. Schuling | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Aug 2015 | 18,000 | 18,000 | - | - | Stock Option (Right to Buy) | |
| David A. Gonyer | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Aug 2015 | 18,000 | 18,000 | - | - | Stock Option (Right to Buy) | |
| David A. Gonyer | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Aug 2015 | 4,125 | 5,500 | - | - | Common Stock | |
| David A. Gonyer | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Aug 2015 | 5,000 | 10,500 | - | - | Common Stock | |
| David A. Gonyer | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Aug 2015 | 4,125 | 0 | - | - | Restricted Stock Units | |
| Tamara A. Seymour | CFO, Secretary, Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Aug 2015 | 23,000 | 69,000 | - | - | Restricted Stock Units | |
| Tamara A. Seymour | CFO, Secretary, Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 04 Aug 2015 | 8,522 | 14,478 | - | - | Common Stock | |
| Tamara A. Seymour | CFO, Secretary, Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Aug 2015 | 23,000 | 23,000 | - | - | Common Stock | |
| Robin L. Smith | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2015 | 1,375 | 1,375 | - | - | Common Stock | |
| Robin L. Smith | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2015 | 1,375 | 4,125 | - | - | Restricted Stock Units | |
| Douglas A. Schuling | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2015 | 1,375 | 1,375 | - | - | Common Stock | |
| Douglas A. Schuling | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2015 | 1,375 | 4,125 | - | - | Restricted Stock Units | |
| David A. Gonyer | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2015 | 1,375 | 4,125 | - | - | Restricted Stock Units | |
| David A. Gonyer | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2015 | 1,375 | 1,375 | - | - | Common Stock | |
| Samuel D. Riccitelli | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Jun 2015 | 124,252 | 248,503 | - | - | Restricted Stock Units | |
| Samuel D. Riccitelli | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Jun 2015 | 124,252 | 377,166 | - | - | Common Stock | |
| Samuel D. Riccitelli | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 19 Jun 2015 | 46,036 | 331,130 | - | - | Common Stock | |
| Robin L. Smith | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2014 | 6,000 | 6,000 | - | - | Stock Option (right to buy) | |
| Robin L. Smith | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2014 | 5,500 | 5,500 | - | - | Restricted Stock Units | |
| Douglas A. Schuling | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2014 | 6,000 | 6,000 | - | - | Stock Option (right to buy) | |
| Douglas A. Schuling | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2014 | 5,500 | 5,500 | - | - | Restricted Stock Units | |
| David A. Gonyer | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2014 | 6,000 | 6,000 | - | - | Stock Option (right to buy) | |
| David A. Gonyer | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2014 | 5,500 | 5,500 | - | - | Restricted Stock Units |